Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: CNY
Haofan Biotech: Report for the third quarter of 2024
Oct 30 00:00
Haofan Biology: 2024 Semi-Annual Report
Aug 28 00:00
Haofan Biology: Summary of the 2024 Semi-Annual Report
Suzhou Highfine Biotech: 2024 First Quarter Report
Apr 26 00:00
Read more
Updated: Nov 16, 2024
Strong Buy
Buy
Hold
Underperform
Sell
No Data